| Heart failure with reduced ejection fraction: a review SP Murphy, NE Ibrahim, JL Januzzi Jama 324 (5), 488-504, 2020 | 546 | 2020 |
| Inflammation in Heart Failure: JACC State-of-the-Art Review SP Murphy, R Kakkar, CP McCarthy, JL Januzzi Jr Journal of the American College of Cardiology 75 (11), 1324-1340, 2020 | 381 | 2020 |
| Association between immune checkpoint inhibitors with cardiovascular events and atherosclerotic plaque ZD Drobni, RM Alvi, J Taron, A Zafar, SP Murphy, PK Rambarat, ... Circulation 142 (24), 2299-2311, 2020 | 327 | 2020 |
| Cardiovascular magnetic resonance in immune checkpoint inhibitor-associated myocarditis L Zhang, M Awadalla, SS Mahmood, A Nohria, MZO Hassan, F Thuny, ... European heart journal 41 (18), 1733-1743, 2020 | 259 | 2020 |
| Global longitudinal strain and cardiac events in patients with immune checkpoint inhibitor-related myocarditis M Awadalla, SS Mahmood, JD Groarke, MZO Hassan, A Nohria, A Rokicki, ... Journal of the American College of Cardiology 75 (5), 467-478, 2020 | 212 | 2020 |
| Major adverse cardiovascular events and the timing and dose of corticosteroids in immune checkpoint Inhibitor–Associated myocarditis L Zhang, DA Zlotoff, M Awadalla, SS Mahmood, A Nohria, MZO Hassan, ... Circulation 141 (24), 2031-2034, 2020 | 165 | 2020 |
| Left ventricular thrombus: contemporary etiologies, treatment strategies, and outcomes CP McCarthy, S Murphy, RV Venkateswaran, A Singh, LL Chang, ... Journal of the American College of Cardiology 73 (15), 2007-2009, 2019 | 93 | 2019 |
| Misclassification of myocardial injury as myocardial infarction: implications for assessing outcomes in value-based programs C McCarthy, S Murphy, JA Cohen, S Rehman, M Jones-O’Connor, ... JAMA cardiology 4 (5), 460-464, 2019 | 82 | 2019 |
| Influenza vaccination and myocarditis among patients receiving immune checkpoint inhibitors M Awadalla, DLA Golden, SS Mahmood, RM Alvi, ND Mercaldo, ... Journal for immunotherapy of cancer 7, 1-10, 2019 | 70 | 2019 |
| Atrial natriuretic peptide and treatment with sacubitril/valsartan in heart failure with reduced ejection fraction SP Murphy, MF Prescott, A Camacho, SR Iyer, AS Maisel, GM Felker, ... Heart failure 9 (2), 127-136, 2021 | 63 | 2021 |
| Early clinical and sociodemographic experience with patients hospitalized with COVID-19 at a large American healthcare system CP McCarthy, S Murphy, M Jones-O'Connor, DS Olshan, JR Khambhati, ... EClinicalMedicine 26, 2020 | 60 | 2020 |
| Decline of erythromycin resistance of group A β-hemolytic streptococci in Japan: comparison with worldwide reports JW Bass, ME Weisse, MR Plymyer, S Murphy, BJ Eberly Archives of pediatrics & adolescent medicine 148 (1), 67-71, 1994 | 56 | 1994 |
| Immune checkpoint inhibitors for cancer and venous thromboembolic events J Gong, ZD Drobni, RM Alvi, SP Murphy, RJ Sullivan, SE Hartmann, ... European Journal of Cancer 158, 99-110, 2021 | 49 | 2021 |
| Electrocardiographic features of immune checkpoint inhibitor associated myocarditis DA Zlotoff, MZO Hassan, A Zafar, RM Alvi, M Awadalla, SS Mahmood, ... Journal for immunotherapy of cancer 9 (3), 2021 | 45 | 2021 |
| The incidence, risk factors, and outcomes with 5-fluorouracil–associated coronary vasospasm A Zafar, ZD Drobni, R Mosarla, RM Alvi, M Lei, UY Lou, VK Raghu, ... Cardio Oncology 3 (1), 101-109, 2021 | 41 | 2021 |
| Longitudinal SARS-CoV-2 RNA wastewater monitoring across a range of scales correlates with total and regional COVID-19 burden in a well-defined urban population N Acosta, MA Bautista, BJ Waddell, J McCalder, AB Beaudet, L Man, ... Water Research 220, 118611, 2022 | 40 | 2022 |
| Association between angiotensin receptor–neprilysin inhibition, cardiovascular biomarkers, and cardiac remodeling in heart failure with reduced ejection fraction SP Murphy, MF Prescott, AS Maisel, J Butler, IL Piña, GM Felker, JH Ward, ... Circulation: Heart Failure 14 (6), e008410, 2021 | 30 | 2021 |
| Cardiologist evaluation of patients with type 2 myocardial infarction CP McCarthy, DS Olshan, S Rehman, M Jones-O’Connor, S Murphy, ... Circulation: Cardiovascular Quality and Outcomes 14 (1), e007440, 2021 | 18 | 2021 |
| Early B-type natriuretic peptide change in HFrEF patients treated with sacubitril/valsartan: a pooled analysis of EVALUATE-HF and PROVE-HF PL Myhre, MF Prescott, SP Murphy, JC Fang, GF Mitchell, JH Ward, ... Heart Failure 10 (2), 119-128, 2022 | 17 | 2022 |
| Challenges and lessons learned for acute inpatient rehabilitation of persons with COVID-19: clinical presentation, assessment, needs, and services utilization S Maltser, E Trovato, HN Fusco, CP Sison, AF Ambrose, J Herrera, ... American journal of physical medicine & rehabilitation 100 (12), 1115-1123, 2021 | 17 | 2021 |
